Article
Successful Treatment of Metastatic Gallbladder Carcinoma with a High Tumor Mutational Burden Using Pembrolizumab.
Internal medicine (Tokyo, Japan) - 1 Nov 2023
Uehara Sanae, Naganuma Atsushi, Furuichi Nozomi, Furusawa Ai, Kaburagi Takuya, Naruse Hiroaki, Tomaru Shota, Sano Nozomi, Suzuki Yuhei, Masuda Tomoyuki, Hoshino Takashi, Yasuoka Hidetoshi, Tanaka Yuko, Saito Shuichi, Hatanaka Takeshi, Kakizaki Satoru
Abstract excerpt
A woman in her 70s presented with gallbladder carcinoma with liver metastases and peritoneal dissemination. After standard chemotherapy failed, a liver biopsy was performed. A FoundationOne CDx analysis showed that the tumor mutational burden (TMB) was high (34 mutations/megabase). Treatment with pembrolizumab, which is an immune checkpoint inhibitor (ICI), resulted in a partial response, and there were no...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.